Camrelizumab Plus Apatinib in Patients With High-risk Gestational Trophoblastic Neoplasia

Condition:   Gestational Trophoblastic Neoplasia Interventions:   Drug: Camrelizumab plus apatinib CohortA;   Drug: Camrelizumab plus apatinib Cohort B Sponsors:   Peking Union Medical College Hospital;   Jiangsu HengRui Medicine Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials